NCT00794053

Brief Summary

Detection of lymph nodes starting to be involved by cancer spreading from the thyroid gland during operation is useful. It saves the patient from having a second operation to remove these nodes later on when they become obvious. The problem is that there are many lymph nodes around the gland. The theory is that only one node will get the first spill of the tumour cells. In this study the investigators are trying to use an inert colored material to inject into the tumour. This should run in the same path as the tumour cells and should therefore stain the one lymph node that will be affected first should the tumour spread. The stained lymph node is excised and examined instantaneously for tumour affection. If it is found to be affected by the tumour, then the operation is extended to include removal of all its fellow lymph nodes. If it is found to be free from the tumour, then this patient does not have tumour spread.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
45

participants targeted

Target at below P25 for phase_3

Timeline
Completed

Started Dec 2002

Longer than P75 for phase_3

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2002

Completed
6 years until next milestone

First Submitted

Initial submission to the registry

November 18, 2008

Completed
1 day until next milestone

First Posted

Study publicly available on registry

November 19, 2008

Completed
12 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2008

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2009

Completed
Last Updated

July 15, 2009

Status Verified

July 1, 2009

Enrollment Period

6 years

First QC Date

November 18, 2008

Last Update Submit

July 14, 2009

Conditions

Keywords

Sentinel lymph nodethyroid cancerneck dissection

Outcome Measures

Primary Outcomes (1)

  • The lymph nodes around the thyroid tumour will be removed and examined under microscopy in all study subjects to verify that the stained node is a true representative to the state of lymph nodes as regards tumour spread

    the lymph nodes removed during the surgery will be examined the next day of the operation

Study Arms (1)

study group

EXPERIMENTAL

The members in this group will undergo intervention by having surgery and lymph node detection by dye staining

Procedure: detecting lymph node metastasis by staining

Interventions

this started by collar incision, development of sub-platysmal skin flaps and separation of strap muscles in the midline. This was followed by exposure of the thyroid gland; identification of the thyroid tumour; injection of the dye into the tumour; waiting for the dye to reach the lymph nodes; identifying the stained node; labeling it as the sentinel node (SLN); performing total thyroidectomy and bilateral central neck dissection.

Also known as: sentinel lymph node detection, staging of thyroid cancer
study group

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Patient diagnosed to have differentiated thyroid carcinoma and has no detectable cervical lymphadenopathy.

You may not qualify if:

  • Previous neck surgery, pregnancy and known hypersensitivity to the dye used.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Alexandria University Hospitals

Alexandria, Alexandria Governorate, 110226, Egypt

Location

MeSH Terms

Conditions

Thyroid NeoplasmsLymphatic Metastasis

Condition Hierarchy (Ancestors)

Endocrine Gland NeoplasmsNeoplasms by SiteNeoplasmsHead and Neck NeoplasmsEndocrine System DiseasesThyroid DiseasesNeoplasm MetastasisNeoplastic ProcessesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Yasser M Hamza, A Professor

    University of Alexandria

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 3
Allocation
NA
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER

Study Record Dates

First Submitted

November 18, 2008

First Posted

November 19, 2008

Study Start

December 1, 2002

Primary Completion

December 1, 2008

Study Completion

April 1, 2009

Last Updated

July 15, 2009

Record last verified: 2009-07

Locations